Investors are Angry with Botox-Maker Allergan — and They're Trying to Get an Activist Involved to Shake It Up
Read Full Article
- Some of Allergan's top shareholders have approached potential activist investors to gauge their interest in pushing for change at the Botox-maker, according to people familiar with the matter.
- Allergan's shares are down 33% in the last year, compared to a 7% rise for the Nasdaq Biotech Index.
- Allergan is set to report earnings on April 30...